Finally, in a clinical study examining the effect of resveratrol, a mitochondrial antioxidant, it had no effect on exercise tolerance or whole-body fatty acid oxidation in patients with VLCAD or CPT2 deficiency. Here, CPT2 is linked to very long chain acyl-CoA dehydrogenase deficiency.